Evidence map›Paper›PMID 35466569›Full record

ArticlePhysiological reports2022

Changes in P2Y

André Erdling, Sara Ellinor Johansson, Aneta Radziwon-Balicka, Saema Ansar, Lars Edvinsson

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Changes in P2YPhysiological reports · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

André ErdlingDepartment of Clinical Sciences, Division of Experimental Vascular Research, Lund University, Lund, Sweden.ORCID 0000-0002-6309-242X
Sara Ellinor JohanssonDepartment of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet-Glostrup, Glostrup, Denmark.
Aneta Radziwon-BalickaDepartment of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet-Glostrup, Glostrup, Denmark.
Saema AnsarApplied Neurovascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lars EdvinssonDepartment of Clinical Sciences, Division of Experimental Vascular Research, Lund University, Lund, Sweden.
Lund University · SEGlostrup Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia, both in the form of focal thromboembolic stroke and following subarachnoid hemorrhage (SAH), causes upregulation of vasoconstrictive receptor systems within the cerebral vasculature. Descriptions regarding changes in purinergic signaling following ischemia are lacking, especially when the importance of purinergic signaling in regulating vascular tone is taken into consideration. This prompted us to evaluate changes in P2Y

Indexed as

StrokeVasoconstrictionAnimalsInfarction, Middle Cerebral ArteryIschemiaRatsReceptors, Purinergic P2Uridine Diphosphatepurinoceptor P2Y6Receptors, Purinergic P2Uridine DiphosphateMCAOP2Y6purinergicratSAHstroke

Identifiers

PMID35466569
PMCPMC9035753
OpenAlexW4224325219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.